BSE filing, NSE: RAINBOW. Summary written from the filing by ALFA Finder's alert engine.
Rainbow Childrens Medicare Ltd: key numbers
- Share price
- ₹1,204.80
- Market cap
- ₹12,237 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 42.9×Sector 52.0×
- Promoter holding
- 49.83%-0.01% QoQ
- FII holding
- 14.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rainbow Childrens Medicare Ltd
All →Rainbow Childrens Medicare Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Rainbow Childrens Medicare Capacity Expansion
Rainbow Children’s Medicare entered a 60-year lease for 2 acres in Amaravati with APCRDA. The site will house a new 250-bed super speciality children’s hospital.
- From
- Andhra Pradesh Capital Region Development Authority (APCRDA)
- Execution
- 60 years
- hospital beds
- 250.0 beds
Rainbow Childrens Medicare Credit Rating
ICRA Limited has reaffirmed the [ICRA] AA (Stable) issuer rating for Rainbow Children's Medicare Limited. This periodic rating review confirms the company's existing credit standing.
Rainbow Childrens Medicare Management Change
Rainbow Childrens Medicare Limited has appointed Mr. Sudarshan Patodia as the Chief Financial Officer, effective September 23, 2026.
Rainbow Childrens Medicare Employee Stock Options
Rainbow Children's Medicare Limited granted 55,690 stock options to eligible employees under its ESOP 2025 scheme.
Rainbow Childrens Medicare Other Announcement
Rainbow Children's Medicare Limited has submitted the updated contact details of its Key Managerial Personnel authorized under SEBI (LODR) Regulations, 2015, for exchange records.
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.